Alkermes Takes Bigger 1Q Loss on Lower Revenue

Published August 7, 2010

Alkermes takes bigger 1Q loss on lower revenue
Alkermes Inc., which is waiting for regulators to make a decision on two key drug candidates, said Thursday that its first-quarter loss grew as its revenue decreased.In October, the Food and Drug Administration is scheduled to make decisions on the company’s Vivitrol as a treatment for opioid…
Read more on Manufacturing.net

Alkermes takes bigger 1Q loss on lower revenue
Alkermes Inc., which is waiting for regulators to make a decision on two key drug candidates, said Thursday that its first-quarter loss grew as its revenue decreased.
Read more on AP via Yahoo! Finance